drugset / Trial / NCT01264133

A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

NCT01264133

Phase 4 Terminated 200 enrolled Bukwang Pharmaceutical
FactorialOpen-labelTreatment

Summary

An open study to Evaluate the Efficacy, Safety and Sustained effect of Clevudine monotherapy or Adefovir and Clevudine combination in proportion to Roadmap concept in Patients with chronic hepatitis B.

Timeline

Start
2009-09
Primary completion
2013-06
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown 10 mg
Subject Clevudine Small molecule 30 mg